Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation.
Oncogenesis
Xu, J J; Pfarr, N N; Endris, V V; Mai, E K EK; Md Hanafiah, N H NH; Lehners, N N; Penzel, R R; Weichert, W W; Ho, A D AD; Schirmacher, P P; Goldschmidt, H H; Andrulis, M M; Raab, M S MS
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes.
Blood
Kortüm, K Martin KM; Mai, Elias K EK; Hanafiah, Nur H NH; Shi, Chang-Xi CX; Zhu, Yuan-Xiao YX; Bruins, Laura L; Barrio, Santiago S; Jedlowski, Patrick P; Merz, Maximilian M; Xu, Jing J; Stewart, Robert A RA; Andrulis, Mindaugas M; Jauch, Anna A; Hillengass, Jens J; Goldschmidt, Hartmut H; Bergsagel, P Leif PL; Braggio, Esteban E; Stewart, A Keith AK; Raab, Marc S MS
Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes.
British Journal Of Cancer
Kratz, C P CP; Franke, L L; Peters, H H; Kohlschmidt, N N; Kazmierczak, B B; Finckh, U U; Bier, A A; Eichhorn, B B; Blank, C C; Kraus, C C; Kohlhase, J J; Pauli, S S; Wildhardt, G G; Kutsche, K K; Auber, B B; Christmann, A A; Bachmann, N N; Mitter, D D; Cremer, F W FW; Mayer, K K; Daumer-Haas, C C; Nevinny-Stickel-Hinzpeter, C C; Oeffner, F F; Schlüter, G G; Gencik, M M; Überlacker, B B; Lissewski, C C; Schanze, I I; Greene, M H MH; Spix, C C; Zenker, M M